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Abstract 
 
Introduction: The enzyme steroid sulfatase converts sulfated steroids to their non-sulfated forms. 
Deficiency for this enzyme is associated with inattention but preserved response control. The 
polymorphism rs17268988 within the X-linked steroid sulfatase gene (STS) is associated with 
inattentive, but not other, symptoms in boys with Attention Deficit Hyperactivity Disorder (ADHD).  
Methods: We initially tested whether rs17268988 genotype was associated with attention, response 
control and underlying aspects of cognition, using questionnaires and neuropsychological tasks, in two 
independent cohorts of healthy adult males. In an additional analysis based upon existing data, the 
performance of mice with genetic or pharmacological manipulations of the steroid sulfatase axis 
under attentionally-demanding conditions was investigated.   
Results: G-allele carriers at rs17268988 exhibited reduced reaction time, enhanced attention and 
reduced reaction time variability relative to C-allele carriers. Mice with genetic or pharmacological 
manipulations of the steroid sulfatase axis were shown to have perturbed reaction time variability.  
Discussion: Our findings provide additional support for an association between rs17268988 genotype 
and attention, which may be partially mediated by reaction time variability; they also indicate that, in 
contrast to the situation in boys with ADHD, in healthy men, the G allele at rs17268988 is associated 
with enhanced cognition. As reaction time variability is a predictor of wellbeing, rs17268988 genotype 
may represent a biomarker for long-term health.   
 
 
Keywords: coefficient of variation; intra-individual reaction time variability; RRID: SCR_014794; 5-
choice serial reaction time task (5-CSRTT) 
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Introduction 
The enzyme steroid sulfatase, encoded by the X-linked gene STS, cleaves sulfate groups from 
a variety of steroids (e.g. dehydroepiandrosterone sulfate, DHEAS) to convert them to precursors for 
a variety of oestrogens and androgens that can elicit widespread and profound physiological effects 
(Mueller et al., 2015). Studies in rodent models have implicated steroid sulfatase function in a number 
of aspects of cognition, including memory (Babalola et al., 2012; Johnson et al., 2000). Mice lacking 
the Sts gene, or given an inhibitor of the enzyme, display attentional deficits relative to wildtype or 
vehicle-treated mice manifest as increased omission or commission errors respectively (Davies et al., 
2009); interestingly, contrary to expectation, the former groups exhibit enhanced response inhibition 
relative to wildtype or vehicle-treated mice (Davies et al., 2014). Somewhat consistent with these 
mouse data, males lacking a functional STS gene are at increased risk of developing Attention Deficit 
Hyperactivity Disorder (ADHD)(particularly the inattentive presentation) but seem to exhibit normal 
levels of motor impulsivity (Chatterjee et al., 2016; Kent et al., 2008). In the developing human brain, 
STS is highly expressed in brain regions important in attention and response control, notably the 
thalamus and the basal ganglia (Stergiakouli et al., 2011). Two independent genetic association studies 
examining the STS gene in boys from UK with ADHD identified the single nucleotide polymorphism 
(SNP) rs17268988 as being associated with inattentive symptoms, but not hyperactive or impulsive 
symptoms (Brookes et al., 2008; Stergiakouli et al., 2011); specifically the G allele at this SNP was 
associated with a greater number of inattentive symptoms. No other SNPs around the STS gene 
showed evidence for association with disorder symptoms.  
In the present study, we tested whether rs17268988 genotype was associated with aspects of 
attention or impulsivity in healthy adult males with a view to understanding how this polymorphism, 
or polymorphisms in linkage disequilibrium with it, may predispose to inattention in ADHD. Our main 
hypothesis was that possession of a G allele at this locus would be associated with impaired attention, 
but normal (or perhaps even enhanced) response inhibition. We subsequently tested whether our 
human findings were consistent with previously-obtained data from our mouse model studies.  
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Materials and Methods 
 
Participants 
 
Cohort 1 (n=132 males aged 18-70yrs (mean 37±2yrs), self-reported as being cognitively healthy) was 
recruited via the Electronic Management System or Community Panel within the School of Psychology 
at Cardiff University, or from an internal University advert; recruitment and testing procedures were 
approved by Cardiff University School of Psychology Ethics Committee. Cohort 2 (n=244 males, aged 
18-70yrs (mean 51±1yrs)) was recruited from around Munich, Germany and screened as described 
previously (Stergiakouli et al., 2011); recruitment, screening and testing procedures were approved 
by the Institutional Review Board of the Ludwig-Maximilians University of Munich. The two cohorts 
were assumed to be representative of the general populations of the UK and Germany respectively 
and were predominantly of White European ethnicity. Experiments were undertaken with the 
understanding and written consent of each subject. 
 
Genotyping procedures 
 
UK participants provided a saliva sample from which DNA was extracted using standard laboratory 
procedures; amplicons encompassing rs17268988 were produced by PCR (Forward primer: 5’-
CCAAAGGAGGGGTGTGTAAT-3’; Reverse primer 5’-GTAAAATCGCAAGCCCATGT-3’) and sequenced. 
German participants were genotyped as described previously (Stergiakouli et al., 2011). As the STS 
gene is X-linked, hemizygous males can only have either C or G alleles at rs17268988. 
 
Questionnaires 
 
Cohort 1 completed an initial demographic questionnaire to take into account factors that could 
feasibly influence performance on the neuropsychological tests. Specifically, participants were asked 
to report age, handedness, levels of tiredness (scale of 0-10, not tired to exhausted respectively), 
stress levels (0-10, not stressed to extremely stressed respectively), recent caffeine and alcohol 
consumption, smoking status (i.e. nicotine consumption), and video-game playing frequency. A subset 
of Cohort 1 (subset A, n=65) were administered two questionnaires assaying attention and impulsivity: 
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the 30-item Barrett Impulsiveness Scale-11 (BIS-11) (Patton et al., 1995) and the 59-item UPPS-P 
Impulsive Behaviour Scale (Lynam et al., 2006). BIS-11 provided an overall measure of impulsiveness, 
together with sub-scale measures of attentional, motor and non-planning impulsiveness. The UPPS-P 
Impulsive Behaviour Scale provided an overall measure of impulsiveness, together with sub-measures 
of negative and positive urgency, lack of premeditation and lack of perseverance, and sensation-
seeking. The remainder of Cohort 1 (subset B, n=67) were administered an 18-item questionnaire 
based upon DSM-IV criteria for Attention Deficit Hyperactivity Disorder, with level of agreement with 
each symptom being scored on a Likert scale from 1 (‘never true of me’) to 5 (‘always true of me’). 
This questionnaire provided an overall level of ADHD traits and relative levels of inattention and 
hyperactive-impulsive traits (nine items each).  
 
Neuropsychological tests 
 
All Cohort 1 participants were administered two neuropsychological tests taxing attention, impulsivity 
and other relevant cognitive measures in the following sequence: i) an adapted version of the Context-
Cuing Task (CCT) (Verbruggen et al., 2010) and ii) the freely-available Psychology Experiment Building 
Language (PEBL) Test of Attentional Vigilance (TOAV) with default settings (Mueller and Piper, 2014; 
RRID:SCR_014794).  
The cognitively-demanding CCT was used to assess ability to withhold a pre-planned motor 
response (response inhibition) and the ability update a response-set so as to execute an additional 
response. Participants were required to make speeded responses to a series of white arrow stimuli 
presented on a laptop screen (Toshiba Satellite Pro), pressing the ‘J’ key for ‘<<<’ and the ‘K’ key for 
‘>>>’. On a proportion of trials, the arrows would turn black after a variable period (the ‘signal’). The 
stimuli and signals appeared within two different task contexts: ‘stop’ and ‘double’. During ‘stop’ 
blocks, participants had to try and withhold their response upon presentation of the ‘stop signal’. 
Based on the horse-race model (Verbruggen and Logan, 2009), a response will be successfully inhibited 
if completion of the stop process (triggered by the signal) occurs before completion of the go process 
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(triggered by the stimulus). Increasing the delay between the stimulus and stop-signal presentation 
(‘stop-signal delay’, SSD) reduces the probability of successfully stopping on stop-signal trials 
(Verbruggen and Logan, 2009). The stop-signal reaction time (SSRT) is a covertly-obtained estimate of 
the latency of the stopping process (Verbruggen and Logan, 2009), and was calculated by an 
integration method (Verbruggen et al., 2010) utilising an automated staircase tracking system in which 
the SSD is increased by 50ms upon successful inhibition and decreased by 50ms when inhibition is 
unsuccessful. During ‘double blocks’, participants had to execute a second response (space bar tap) 
when the ‘dual signal’ appeared, immediately after their primary response to the white arrow 
stimulus. Participants respond more slowly to the dual-signal when the time delay between the 
stimulus and dual-signal, known as the ‘stimulus onset asynchrony’ (SOA) is reduced, due to the 
existence of a ‘psychological refractory period’ (PRP); the double blocks used fixed SOAs of 100, 250 
and 400ms. The PRP provides a measure of the delay in accessing response selection to the dual-signal 
whilst individuals are completing central attentional processes for the initial stimulus (Pashler, 1984). 
The CCT task alternates pseudo-randomly between stop and double blocks, permitting the reaction 
time and the proportion of mistakes made on the first trial following a switch (‘RT Switch’ and ‘Switch 
Cost’ respectively) to be calculated. There are four possible switches: stop-to-dual, dual-to-stop, stop-
to-stop and dual-to-dual; a switch cost of 1 indicates that that every response following a switch was 
incorrect, where as a switch cost of 0 signifies that no errors were made. Successful task switching 
requires the participant to update a response-set, and to exhibit a degree of behavioural flexibility. 
One measure of a participant’s reaction time variability, the ‘coefficient of variation’ (CoV), was 
calculated by dividing the standard deviation of the reaction times by the mean reaction time (Jackson 
et al., 2012); this metric has been used extensively in the literature and is easily calculated. Each 
participant completed one practice run followed by three complete runs, with each run lasting ~7 
minutes and consisting of 12 ‘double’ or ‘stop’ blocks of nine trials each. The results from the three 
runs were averaged to calculate mean scores for each variable of interest. 
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In the TOAV, participants must respond to a black square that briefly appears within a white 
square. The stimulus is a target if it appears in the top portion of the white square; participants must 
respond by pressing the space bar. When the black square appears in the bottom portion of the white 
square it is a non-target and participants must not respond. The test is comprised of two halves: in the 
first half (Block 1) targets appear infrequently (infrequent condition, 72/320 trials), whereas in the 
second half (Block 2), targets are frequently presented (stimulating condition, 248/320 trials); Block 1 
primarily taxes stimulus-detection processes (attention) whereas Block 2 primarily taxes response-
inhibition processes (impulsivity). The test lasts approximately 24min and as such taxes both sustained 
and selective attention. Main measures of interest included: omission errors (i.e. failure to respond to 
target presentation, reflecting attention), commission errors (i.e. response to a non-target, reflecting 
attentional and impulsivity processes), correct reaction time (a measure of information processing 
and motor response time), coefficient of variation (standard deviation of reaction times divided by 
mean reaction time), and response sensitivity (D’), an indicator of the rate of deterioration in task 
performance, and of the accuracy with which targets can be discriminated from non-targets (a 
measure of perceptual sensitivity). 
Males from Cohort 2 underwent a battery of cognitive tasks (Winterer et al., 2010), of which 
the Continuous Performance Task was most relevant to understanding attention. Key measures that 
were available from this sample included number of hits (i.e. responses to targets), false alarms 
(responses to non-targets) and perceptual sensitivity (D’).  
 
Animal studies 
 
We re-analysed data from experiments previously reported in Davies et al. (2009). Briefly, wildtype 
(40,XY, n=9) and Sts-deficient (39,XY*O, n=11) male MF1 mice were tested on the 5-choice serial 
reaction time task (5-CSRTT) of attention, with light stimuli of 0.1, 0.3, 0.5 and 0.7s presented 
pseudorandomly; wildtype male MF1 mice (n=12) treated with both vehicle and the STS inhibitor 
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Coumate (10mg/kg, p.o.) in a randomised order were tested on 5-CSRTT with light stimuli of 0.25, 0.5, 
0.75 and 1.0s presented pseudorandomly.  
 
Statistical analysis 
 
Data were analysed using SPSS 20, and were tested for normality using Shapiro-Wilk test. Normally-
distributed data are presented as mean values ± standard error of the mean, and non-normally-
distributed data as median values with 95% confidence intervals defined by bootstrapping. Human 
data were analysed with two-tailed t-test (unless stated otherwise) if normally-distributed (or if data 
could be normalised with natural log, reciprocal or square root transformation), or with Mann-
Whitney U-test if not normally-distributed, with a between-group factor of genotype (C or G allele). 
Data comparing wildtype to Sts-deficient mice were analysed as above, whilst the effects of Vehicle 
or Coumate treatment on cognitive measures in the same mice were examined using paired t-test or 
Wilcoxon Rank test for normal or non-normally distributed data respectively. Categorical data were 
analysed by Chi-squared Test with Yates’ correction depending upon cell frequency. Correlations were 
performed using Pearson test (with normally-distributed data) or Spearman test (with non-normally 
distributed data). P-values <0.05 were regarded as nominally-significant. 
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Results 
 
Genotyping 
 
103/132 (78%) males in Cohort 1 possessed the C-allele at rs17268988, and 29/132 (22%) the G-allele. 
175/244 (72%) males in Cohort 2 possessed the C-allele, and 69/244 (28%) the G-allele. These data 
are consistent with previously-obtained minor allele frequencies in boys with ADHD from UK and 
Ireland (21-24%), and with data from HapMap CEU male samples from the general population (27%) 
(Stergiakouli et al., 2011).    
 
Demographics 
 
C and G-allele carriers within the ‘discovery sample’ (Cohort 1) were closely matched in terms of 
demographic variables that might feasibly have affected their performance on the neuropsychological 
tasks (Table 1). C and G-allele carriers within Cohort 2 were matched in terms of their age: C: 57 
(95%CI: 53-59) vs. G: 51 (95%: 48-58.5), p=0.26.     
  
Questionnaire-based measures 
 
Levels of inattention and impulsivity within Cohort 1, as indexed by questionnaire-based measures, 
were relatively low and comparable with previous data in healthy adult male populations (Cyders, 
2013; Stanford et al., 2009). We found no evidence that males with C or G alleles differed from one 
another in terms of their self-reported impulsivity scores on the BIS-11 or UPPS questionnaires (subset 
A, Table 2), or in terms of their self-reported ADHD-related traits (subset B, Table 3).  
 
Context-cuing task 
 
The majority (89%) of participants from Cohort 1 understood the instructions for performing the CCT 
after a practice block, and exhibited behavioural performance in the task-proper consistent with this. 
Interestingly, a higher proportion of C allele carriers than G allele carriers failed to learn the complex 
task (~12.5% vs. ~7%), perhaps consistent with enhanced general cognitive performance in the latter 
group. Across both types of Block (Dual and Stop), individuals possessing a G allele at rs17268988 
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exhibited a significantly shorter reaction time than individuals possessing a C allele at this locus; the 
former group also presented with shorter reaction times on the first trial of Stop Blocks after switching 
from Dual Blocks (Table 4). C and G allele carriers performed equivalently on all other task measures. 
  
Test of Attentional Vigilance (TOAV) 
 
TOAV performance in the majority of Cohort 1 participants was successfully analysed, although one G 
allele carrier did not complete the task due to fatigue. On Block 1, individuals possessing a G allele 
made significantly more correct responses than C allele carriers, made significantly fewer commission 
errors than C allele carriers, and had significantly lower variability in their reaction times than C allele 
carriers (Table 5); there was a significant positive correlation between the number of commission 
errors and the coefficient of variation across the individual genotypes (C: rs=0.538, p<0.001 and G: rs= 
0.617, p<0.001) and across the two genotypes combined (rs=0.592, p<0.001). C and G allele carriers 
did not differ on any other measures on Block 1. C and G allele carriers did not differ significantly with 
respect to any measure in Block 2; the two groups did not differ significantly with respect to any 
measure across both Blocks 1 and 2 (Table 5).  
 
Continuous Performance Task (CPT) 
 
Based on the TOAV data for Cohort 1, we predicted that, in an independent sample, male carriers of 
a G allele at rs17268988 would exhibit enhanced cognitive performance relative to C allele carriers in 
an attentionally-demanding Continuous Performance Task conceptually analogous to the TOAV. In 
Cohort 2, G allele carriers made more successful responses to targets (‘hits’) and fewer erroneous 
responses to non-targets (‘false alarms’) relative to C carriers (79 (95%CI: 78-79) vs. 78 (95%CI: 78-79) 
and 1 (95%CI: 0-1) vs. 1 (95%CI: 1-1) respectively, one-tailed p=0.068 and p=0.232). D’ for G allele 
carriers was significantly higher than for C allele carriers (5.071 (95%CI: 4.807-5.268) vs. 4.932 (95%CI: 
4.694-4.986), one-tailed p=0.0395) consistent with improved stimulus detection sensitivity in the 
former group.  
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A re-analysis of previously-obtained mouse data 
 
Given the data from the TOAV above, we re-analysed our previously published mouse data (Davies et 
al., 2009) to test whether the genetic or pharmacological manipulations had effects on reaction time 
variability under attentionally-demanding conditions.  
Relative to wildtype MF1 male mice, MF1 Sts-deficient male mice exhibited evidence for 
reduced incorrect reaction time, reduced reaction time variability on incorrect trials, and reduced 
variability in reaction time across all responses (Table 6). When MF1 male mice were administered 
the STS inhibitor Coumate they exhibited evidence for higher numbers of incorrect trials, and 
increased reaction time variability, relative to when they were administered vehicle (Table 7).  
 
Discussion 
 
Mice and human males lacking a functional X-linked STS gene exhibit attentional deficits, and the latter 
group are at increased risk of developing inattentive ADHD (Chatterjee et al., 2016; Davies et al., 2009; 
Kent et al., 2008). There is previous evidence that the number of inattentive symptoms (but not 
impulsive or hyperactive symptoms) in boys with ADHD is associated with variation at the single 
nucleotide polymorphism rs17268988 within STS (Brookes et al., 2008; Stergiakouli et al., 2011). In 
the current study, we tested whether genotype at rs17268988 was associated with questionnaire-
based and neuropsychological measures of attention, response control and cognition in large samples 
of healthy males, and whether similar effects could be seen in mice with genetic or pharmacological 
manipulations of the steroid sulfatase system; these studies could potentially provide insights into the 
psychological and neural processes through which rs17268988 (or polymorphisms in linkage 
disequilbrium with it) could influence attentional (dys)function.  
Converging data from two questionnaires assessing aspects of impulsivity (BIS-11 and UPPS-
P) and a DSM-IV ADHD criteria-derived questionnaire assessing inattention and hyperactivity-
impulsivity indicated that rs17268988 genotype was not associated with large effects on self-reported 
measures of inattention, hyperactivity, or impulsivity. The neuropsychological data however indicated 
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subtle differences in cognition between individuals possessing C and G alleles, notably on measures 
of reaction time, reaction time variability and response accuracy under attentionally-demanding 
conditions; interestingly, the direction of these effects was counter to that which we hypothesised. 
Importantly, the between-group differences were unlikely to be confounded by general factors (e.g. 
tiredness) that could influence task performance. rs17268988 genotype and cognitive performance 
may feasibly be causally-related given previous animal model and clinical data explicitly demonstrating 
a role for steroid sulfatase in cognitive processes (including attention).  It is also worth noting that we 
did not correct for multiple testing given that many of the measures assayed (both significant and not) 
are likely to be inter-dependent; therefore, the aforementioned nominally-significant findings, though 
somewhat replicable, should be treated with an appropriate degree of caution.   
On the cognitively-demanding Context-Cuing Task (CCT) G allele carriers demonstrated 
significantly shorter reaction times than C allele carriers, possibly indicating superior information 
processing and/or more rapid motor responses. Consistent with previous data in boys with ADHD, and 
with the questionnaire data, rs17268988 genotype was not associated with the main CCT measure of 
response inhibition (SSRT). Although G allele carriers tended to show reduced reaction times relative 
to C allele carriers on the TOAV, unlike in the CCT there was no significant effect of genotype; this 
discrepancy could potentially be explained by a ceiling effect in the less complex TOAV. We noted 
significant associations between cognitive measures on the most attentionally-demanding component 
of the TOAV (Block 1) and rs17268988 genotype. Specifically, G allele carriers exhibited evidence for 
more accurate responding, and for responding in a more temporally-consistent manner, relative to C 
allele carriers. As these two variables were significantly correlated with one another across genotypes 
they may be causally related to each other, or alternatively, they may be affected by a common factor. 
C and G allele carriers performed equivalently on Block 2 of the TOAV, an observation consistent with 
the notion that this allele is not associated with effects on impulsivity. Our finding of enhanced 
cognition in G allele carriers under attentionally-demanding conditions was replicated in a large, 
independent healthy male sample; however, it should be appreciated that, given that the cognitive 
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tests employed in Cohorts 1 and 2 differed, the extent to which the findings from Cohort 1 could be 
predicted to generalise to Cohort 2 (and hence, whether a one-tailed p-value is appropriate for Cohort 
2 analysis) is arguable. We chose to use the freely-available TOAV in order that replications of our 
study could be performed readily and cheaply, and we urge other researchers to test whether 
rs17268988 genotype shows a similar pattern of associations in alternative geographically and 
ethnically diverse populations.   
The data presented above provides additional support for the idea that rs17268988 (or a 
linked polymorphism) is associated with aspects of attentional function but not response inhibition. 
However, there is a dissociation between the direction of effects seen in healthy individuals (poorer 
cognitive performance in C allele carriers), and in individuals with ADHD (greater inattention in G allele 
carriers). These contradictory findings could potentially be explained by: i) an interaction between 
rs17268988 genotype, cognitive function and developmental stage (healthy males were aged 18-70, 
boys with ADHD were aged 9-18yrs), ii) an interaction between rs17268988 genotype, cognitive 
function and disorder-specific factors (e.g. alternative genetic risk variants or environmental risk 
factors), iii) differences between clinical symptom scores obtained by child psychiatrists on the basis 
of parental reports and more objective neuropsychological measures, and iv) a combination of one or 
more of the above. With respect to the third possible explanation, there is existing evidence that 
behavioural inattention is not necessarily correlated with cognitive inattention (Jonsdottir et al., 
2006). A final, less likely, explanation for the dissociation is that the findings of enhanced cognition in 
healthy males carrying the G allele and/or the finding of impaired attention in boys with ADHD carrying 
the G allele are false positives arising from limited sample sizes or insufficiently-stringent multiple 
testing correction.  
Data from the TOAV suggested that, under attentionally-demanding conditions, possession of 
a G allele at rs17268988 was associated with reduced variability in reaction time relative to possession 
of a C allele at this locus; the same pattern of effects was not seen when target frequency was high. 
We wanted to examine whether manipulations of the steroid sulfatase axis were associated with 
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altered intra-individual variability in reaction time (as indexed by coefficient of variation) under 
attentionally-demanding conditions in mice. Through a re-analysis of our previously-obtained data, 
we found evidence consistent with the human data which suggested that both genetic and 
pharmacological manipulations of the steroid sulfatase axis influenced reaction time variability: loss 
of the Sts gene was associated with reduced reaction time variability in adult male mice (mainly 
mediated via greater consistency of responding on incorrect trials), whilst acute inhibition of the STS 
enzyme was associated with increased reaction time variability in adult male mice. The opposite 
direction of the genetic and pharmacological effects is intriguing, and could potentially be explained 
by the presence of compensatory processes in the gene deletion model which cannot occur in the 
case of acute enzyme inhibition. Differential behavioural effects in the genetic and pharmacological 
mouse models could also be explained by complete lack of the STS protein in the deletion model 
versus incomplete (~70%) inhibition of the enzyme in the pharmacological model (Nicolas et al., 2001), 
or by deletion of additional genes or genetic elements other than Sts in the genetic model (Trent et 
al., 2014; Trent et al., 2013) and possible off-target effects in the pharmacological model (Ho et al., 
2003). There is a growing body of evidence that pharmacological manipulation of the steroid sulfatase 
axis can influence aspects of cognition and the underlying neural substrates (Yue et al., 2016).  
Should the link between rs17268988 genotype and intra-individual variability in reaction time 
be confirmed in follow-up studies, this could have potentially important implications in terms of 
healthcare. Intra-individual variability in reaction time is influenced by normal (Dykiert et al., 2012) 
and pathological ageing (Phillips et al., 2013) and may be a predictor of early mortality (particularly 
through cardiovascular disease)(Batterham et al., 2014); there have been suggestions that reaction 
time variability may represent a psychological marker of bodily system integrity (Ramchurn et al., 
2014). Thus, any biological factor that significantly influences this construct may represent a potential 
biomarker for lifelong health. The biological mechanisms underlying the association between 
rs17268988 genotype and intra-individual reaction time variability will also warrant investigation. 
There is some evidence that DHEA(S) levels are associated with decline in cognitive performance 
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across ageing in humans (Maggio et al., 2015) and rodents (Chen et al., 2014). At the neuroanatomical 
level, intra-individual variability in reaction time has been most robustly associated with white matter 
volume (Nilsson et al., 2014; Walhovd and Fjell, 2007); STS is expressed within the white matter of the 
human brain, albeit at relatively low levels (Steckelbroeck et al., 2004; Stergiakouli et al., 2011). Hence, 
functional neuroimaging studies in man and mouse may investigate whether the lack of a functional 
STS gene, or of polymorphism at rs17268988, is associated with altered intra-individual reaction time 
variability and alterations in white matter structure, and whether/how any associations are 
modulated by systemic DHEA(S) levels and/or age.    
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Table 1. Demographic variables for healthy adult males recruited from UK with C or G alleles at rs17268988 
 
Demographic variable C-allele carriers (n=103) G-allele carriers (n=29) 
Statistical 
comparison 
Age (yrs) 28 (95%CI: 22.5-49) 23 (95%CI: 22-36) p=0.34 
% right-handed 89 100 p=0.58 
Tiredness level 4 (95%CI: 3-5) 4 (95%CI: 3-4) p=0.12 
Stress level 3 (95%CI: 2-3) 2 (95%CI: 2-3) p=0.38 
Caffeine consumption within past 4hrs 65 16 χ2(1)=0.31, p=0.58 
Number of smokers 7 1 p=1.0 
Significant video-game playing (>once per week) 38 11 χ2(1)=0.01, p=0.92 
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Table 2. Questionnaire-based measures of impulsivity in healthy adult males recruited from UK with C or G alleles at 
rs17268988 (Cohort 1, subset A). BIS-11 (Barrett Impulsiveness Scale-Version 11). 
 
Impulsivity measure C-allele carriers (n=47) G-allele carriers (n=18) 
Statistical 
comparison 
BIS-11 
Total score 65.0±1.4 63.2±2.8 t(63)=0.63, p=0.53 
Attentional impulsiveness 17.7±0.5 16.9±1.1 t(63)=0.70, p=0.49 
Motor impulsiveness 23.8±0.5 22.6±1.1 t(63)=1.14, p=0.26 
Non-planning impulsiveness 23.5±0.7 23.7±1.1 t(63)=-0.17, p=0.87 
UPPS-P Impulsive Behavior Scale 
Total score 135.6±2.7 132.1±5.5 t(63)=0.64, p=0.52 
Negative urgency 26.7±0.8 25.2±1.4 t(63)=1.01, p=0.32 
Lack of premeditation 22.8±0.8 22.2±1.2 t(63)=0.40, p=0.69 
Lack of perseverance 19.0±0.6 19.8±1.4 t(63)=-0.62, p=0.54 
Sensation-seeking 41 (95%CI: 38.5-42.5) 41 (95%CI: 36-42) p=0.47 
Positive urgency 27.6±1.0 26.4±2.0 t(63)=0.62, p=0.54 
 
 
 
Table 3. Questionnaire-based measures of ADHD-related traits in healthy adult males recruited from UK with C or G alleles 
at rs17268988 (Cohort 1, subset B).  
 
ADHD-related traits C-allele carriers (n=56) G-allele carriers (n=11) Statistical comparison 
Total score 39.3±1.0 40.8±1.5 t(65)=-0.63, p=0.53 
Inattention score 20.3±0.6 20.8±0.8 t(65)=-0.36, p=0.72 
Hyperactive-impulsive score 18 (95%CI: 17-20) 20 (95%CI: 17-23) P=0.32 
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Table 4. Context cuing task measures in healthy adult males recruited from UK with C or G alleles at rs17268988 
 C-allele carriers (n=90) G-allele carriers (n=27) Statistical comparison 
Reaction time across Dual and Stop 
Blocks (ms) 
470 (95%CI: 438-550) 428 (95%CI: 401-470) P=0.030 
Coefficient of variation of reaction 
time across Dual and Stop Blocks 
0.247 (95%CI: 0.236-0.265) 0.229 (95%CI: 0.200-0.253) t(115)=1.28, p=0.203 
Reaction time on Dual Blocks (ms) 455 (95%CI: 428-526) 415 (95%CI: 391-445) P=0.037 
Coefficient of variation of reaction 
time on Dual Blocks  
0.234 (95%CI: 0.224-0.249) 0.218 (95%CI: 0.196-0.235) t(115)=1.64, p=0.104 
Reaction time on Stop Blocks including 
erroneous responses on stop trialsa, or 
excluding such responsesb (ms) 
480 (95%CI: 451-590)a 
 
474 (95%CI: 446-564)b 
430 (95%CI: 420-490)a 
 
436 (95%CI: 420-528)b 
P=0.046a 
 
P=0.038b 
Coefficient of variation of reaction 
time on Stop Blocks including 
erroneous responses on Stop trials  
0.243 (95%CI: 0.229-0.259) 0.232 (95%CI: 0.204-0.278) t(115)=0.82, p=0.416 
Stop Signal Reaction Time (ms) 290 (95%CI: 276-309) 283 (95%CI: 255-349) P=0.426 
Psychological refractory period 
(PRP)(ms) 
434 (95%CI: 362-524) 409 (95%CI: 268-571) t(106)=0.945, p=0.347 
Switch cost (Stop-Dual) 0.905 (95%CI: 0.867-0.933) 0.933 (95%CI: 0.875-0.933) P=0.816 
Switch cost (Dual-Stop) 0.895 (95%CI: 0.867-0.909) 0.867 (95%CI: 0.800-0.900) P=0.089 
Switch cost (Dual-Dual) 1.000 (95%CI: 1.000-1.000) 1.000 (95%CI: 1.000-1.000) P=0.542 
Switch cost (Stop-Stop) 0.889 (95%CI: 0.834-0.889) 0.889 (95%CI: 0.833-1.000) P=0.753 
Switch reaction time (Stop-Dual)(ms) 476 (95%CI: 456-531) 413 (95%CI: 403-495) P=0.095 
Switch reaction time (Dual-Stop)(ms) 513 (95%CI: 457-561) 446 (95%CI: 403-493) P=0.024 
Switch reaction time (Dual-Dual)(ms) 444 (95%CI: 432-505) 431 (95%CI: 417-462) P=0.112 
Switch reaction time (Stop-Stop)(ms) 545 (95%CI: 490-587) 463 (95%CI: 416-532) P=0.056 
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Table 5. Test of Attentional Vigilance (TOAV) measures in healthy adult males recruited from UK with C or G alleles at 
rs17268988. 
 
 C-allele carriers (n=103) G-allele carriers (n=28) Statistical comparison 
Block 1 
Correct trials 316 (95%CI: 316-317) 318 (95%CI: 316-318) P=0.037 
Commission errors 3 (95%CI: 2-4) 2 (95%CI: 1-2) P=0.036 
Omission errors 0 (95%CI: 0-0) 0 (95%CI: 0-0) P=0.426 
Correct reaction time (ms) 434.5 (95%CI: 412-446) 424 (95%CI: 401-462) t(129)=0.036, p=0.972 
Incorrect reaction time (ms) 434.5 (95%CI: 379-516) 430 (95%CI: 383-537.5) 0.814 
Coefficient of variation 0.195 (95%CI: 0.187-0.215 0.176 (95%CI: 0.150-0.203) t(129)=-2.049, p=0.042 
D’ 1.615 (95%CI: 0.352-1.858) 1.615 (95%CI: 0.000-1.858) P=0.410 
Block 2 
Correct trials 307 (95%CI: 304-311) 306 (95%CI: 301-311) P=0.344 
Commission errors 11 (95%CI: 9-14) 11 (95%CI: 8-16) P=0.886 
Omission errors 1 (95%CI: 0-1) 1 (95%CI: 0-2) P=0.283 
Correct reaction time (ms) 377 (95%CI: 354-391) 351 (95%CI: 328-377) t(129)=-0.385, p=0.701 
Incorrect reaction time (ms) 323 (95%CI: 316-338) 301 (95%CI: 281.5-353) P=0.352 
Coefficient of variation 0.201 (95%CI: 0.189-0.214) 0.204 (95%CI: 0.162-0.242) t(129)=-0.293, p=0.770 
D’ 1.858 (95%CI: 1.682-2.368) 1.742 (95%CI: 1.208-2.322) P=0.353 
Combined Blocks 1 and 2 
Correct trials 624.5 (95%CI: 620-627) 624 (95%CI: 617.5-628) P=0.751 
Commission errors 13 (95%CI: 12-16) 12 (95%CI: 8-20) P=0.633 
Omission errors 1 (95%CI: 1-2) 1 (95%CI: 1-2.5) P=0.499 
Correct reaction time (ms) 386.5 (95%CI: 370-411) 366 (95%CI: 348.5-394.5) P=0.411 
Incorrect reaction time (ms) 346 (95%CI: 335-366) 327.5 (95%CI: 301-387.5) P=0.382 
Coefficient of variation 0.224 (95%CI: 0.207-0.241) 0.211 (95%CI: 0.190-0.265) t(129)=-0.586, p=0.559 
D’ 1.034 (95%CI: 0.883-1.244) 0.895 (95%CI: 0.645-1.360) P=0.416 
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Table 6. Performance of wildtype (40,XY) and Sts-deficient (39,XY*O) MF1 mice on 5-choice serial reaction time task under 
attentionally-demanding conditions.  
 
 40,XY (n=9) 39,XY*O (n=11) Statistical comparison 
Correct trials 29.8±4.6 34.6±4.0 t(16)=-1.268, p=0.223 
Correct reaction time (ms) 766.5 (95%CI: 639.6-864.1) 799.5 (95%CI: 717.3-917.5) t(16)=1.588, p=0.132 
Coefficient of variation on 
correct trials 
0.390 (95%CI: 0.370-0.930) 0.435 (95%CI: 0.370-0.505) t(16)=-1.039, p=0.314 
Incorrect trials 5.6±1.1 6.2±1.3 t(16)=-0.706, p=0.490 
Incorrect reaction time (ms) 2244±247 1154±101 t(16)=5.802, p<0.001 
Coefficient of variation on 
incorrect trials 
0.737±0.058 0.423±0.059 t(16)=3.727, p=0.002 
All trials (correct and 
incorrect) 
35.3±4.3 40.8±4.7 t(16)=-1.335, p=0.201 
Reaction time across all trials 
(ms) 
1005.0 (95%CI: 858.5-1301.9) 842.0 (95%CI: 754.8-1014.9 t(16)=-1.534, p=0.145 
Coefficient of variation on all 
trials 
0.894±0.089 0.491±0.047 t(16)=5.149, p<0.001 
 
Table 7. Performance of a group of MF1 male mice administered vehicle, or the STS inhibitor Coumate, on 5-choice serial 
reaction time task under attentionally-demanding conditions. 
 
 Vehicle (n=12) Coumate (n=12) Statistical comparison 
Correct trials 36.9±3.6 37.3±4.4 t(11)=-0.096, p=0.925 
Correct reaction time (ms) 852.7±74.0 837.9±56.8 t(11)=0.331, p=0.746 
Coefficient of variation on correct trials 0.635±0.093 0.662±0.079 t(11)=-0.269, p=0.793 
Incorrect trials 3.5 (95%CI: 1-9.5) 8.5 (95%CI: 7.0-14.5) P=0.032 
Incorrect reaction time (ms) 1482.2±178.3 1782.3±143.6 t(9)=-1.408, p=0.193 
Coefficient of variation on incorrect trials 0.674±0.068 0.774±0.055 t(9)=-1.357, p=0.208 
All trials (correct and incorrect) 43.5±4.9 48.8±5.4 t(11)=-1.033, p=0.324 
Reaction time across all trials (ms) 943.9±89.9 1084.9±84.3 t(11)=-1.676, p=0.122 
Coefficient of variation on all trials 0.717±0.070 0.867±0.054 t(11)=-2.274, p=0.044 
 
